Literature DB >> 31172563

Malignant transformation rate of oral leukoplakia in an Australian population.

Kate Shearston1, Behrooz Fateh1, Shixiong Tai1, Dzikamai Hove1, Camile S Farah1,2.   

Abstract

OBJECTIVES: Oral leukoplakia (OLK) is one of the most common oral potentially malignant lesions (OPMD) and is reported to undergo malignant transformation (MT) to oral squamous cell carcinoma (OSCC) at rates of between 0.13% and 34%. This study seeks to determine the proportion of OLK lesions that develop into OSCC in an Australian population and assess the risk factors associated with this transformation.
METHODS: The study is a retrospective audit of patients from a private oral medicine clinic, diagnosed with OLK using clinical and histopathological data between 2006 and 2014. Patients were cross-matched with Cancer Registry data for OSCC, and the rate and time to malignant transformation were determined.
RESULTS: Oral leukoplakia patients with histopathological confirmation of their lesions underwent MT at a rate of 1.49% (3/202), with an average time to MT (TMT) of 5.2 years. When patients without histopathological confirmation were assessed, the MT rate was slightly less (1.30%; 4.9 years TMT). Patients who transformed were more likely to be older females with a history of smoking and alcohol use, with OLK present on the tongue or floor of mouth. The rate of oral epithelial dysplasia (OED) in the transformed group was surprisingly low (one third).
CONCLUSIONS: Oral leukoplakia is at a moderate risk of malignant transformation which can be reduced by careful management. Current tools for identifying high-risk OLK, including histopathological assessment of OED, may not capture all lesions that undergo MT and should be supplemented by unbiased molecular biomarkers.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Australia; malignant transformation; oral epithelial dysplasia; oral leukoplakia; oral squamous cell carcinoma

Mesh:

Year:  2019        PMID: 31172563     DOI: 10.1111/jop.12899

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  6 in total

1.  Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders.

Authors:  Luigi Lorini; Michele Tomasoni; Cristina Gurizzan; Chiara Magri; Mattia Facchetti; Simonetta Battocchio; Chiara Romani; Marco Ravanelli; Arianna Oberti; Anna Bozzola; Elena Bardellini; Alberto Paderno; Davide Mattavelli; Davide Lombardi; Alberto Grammatica; Alberto Deganello; Fabio Facchetti; Stefano Calza; Alessandra Majorana; Cesare Piazza; Paolo Bossi
Journal:  Front Oncol       Date:  2022-04-21       Impact factor: 5.738

2.  Benign Alveolar Ridge Keratosis: Clinical and Histopathologic Analysis of 167 Cases.

Authors:  Asma Almazyad; Chia-Cheng Li; Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2020-03-16

3.  Oral tongue leukoplakia: analysis of clinicopathological characteristics, treatment outcomes, and factors related to recurrence and malignant transformation.

Authors:  Shih-Wei Yang; Yun-Shien Lee; Liang-Che Chang; Cheng-Han Yang; Cheng-Ming Luo; Pei-Wen Wu
Journal:  Clin Oral Investig       Date:  2021-01-07       Impact factor: 3.573

4.  Gingival Leukoplakia: Hyperkeratosis with Epithelial Atrophy Is A Frequent Histopathologic Finding.

Authors:  Lama Alabdulaaly; Asma Almazyad; Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2021-05-31

5.  Management of oral leukoplakia by ablative fractional laser-assisted photodynamic therapy: A 3-year retrospective study of 48 patients.

Authors:  Yi-Lin Yao; Yu-Feng Wang; Chen-Xi Li; Lan Wu; Guo-Yao Tang
Journal:  Lasers Surg Med       Date:  2022-03-07

6.  Malignant transformation of oral leukoplakia: a multicentric retrospective study in Brazilian population.

Authors:  J-M Cerqueira; F-S Pontes; A-R Santos-Silva; O-P Almeida; R-F Costa; F-P Fonseca; R-S Gomez; N-C Neto; L-A Miyahara; C-I Rodrigues-Fernandes; E-D Neto; A-L Araújo
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2021-05-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.